A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

NCT05986292 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

10000

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee
Diabetic Neuropathic Pain
Chronic Low-back Pain

Interventions

DRUG: LY3016859 ISA
DRUG: LY3556050 ISA
DRUG: LY3526318 ISA
DRUG: LY3857210 ISA
DRUG: Placebo Oral
DRUG: Placebo

Sponsor

Eli Lilly and Company